Rand Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Rand Wealth's BMY Position: Q3 2018 in Review
Rand Wealth increased its Bristol-Myers Squibb (BMY) stake by 5.1% in Q3 2018, buying an estimated $59.3K and bringing the position to 20,622 shares worth $1.28M. The position accounts for 0.14% of the portfolio, ranked #141.
Rand Wealth first reported a position in BMY in Q2 2013 and has held it in 22 quarters since. The position peaked at $2.8M in Q4 2013. 1,729 funds tracked by Wall St. Rank hold BMY as of Q3 2018.
- Rand Wealth held 20,622 shares of Bristol-Myers Squibb worth $1.28M as of Q3 2018.
- Rand Wealth bought 1,000 Bristol-Myers Squibb shares in Q3 2018, an estimated $59.3K.
- Bristol-Myers Squibb made up 0.14% of Rand Wealth's portfolio in Q3 2018, its #141 holding.
- Rand Wealth first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 22 quarters since.
- Rand Wealth's Bristol-Myers Squibb position peaked at $2.8M in Q4 2013.
- 1,729 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.
Based on Rand Wealth's 13F filing for Q3 2018, filed 13 Nov 2018.